BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu MC, Lee CW, Lee YS, Lian JH, Tsai CL, Liu YP, Wu CH, Tsai CN. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data. World J Gastroenterol 2017; 23(44): 7818-7829 [PMID: 29209123 DOI: 10.3748/wjg.v23.i44.7818]
URL: https://www.wjgnet.com/1948-5182/full/v23/i44/7818.htm
Number Citing Articles
1
Gang Peng, Hongyan Chai, Weizhen Ji, Yufei Lu, Shengming Wu, Hongyu Zhao, Peining Li, Qiping Hu. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinomaBMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-00998-9
2
Valentina Svicher, Romina Salpini, Lorenzo Piermatteo, Luca Carioti, Arianna Battisti, Luna Colagrossi, Rossana Scutari, Matteo Surdo, Valeria Cacciafesta, Andrea Nuccitelli, Navjyot Hansi, Francesca Ceccherini Silberstein, Carlo Federico Perno, Upkar S Gill, Patrick T F Kennedy. Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BGut 2021; 70(12): 2337 doi: 10.1136/gutjnl-2020-323300
3
Valentina Svicher, Romina Salpini, Stefano D’Anna, Lorenzo Piermatteo, Marco Iannetta, Vincenzo Malagnino, Loredana Sarmati. New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesisFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143258
4
Romina Salpini, Stefano D’Anna, Livia Benedetti, Lorenzo Piermatteo, Upkar Gill, Valentina Svicher, Patrick T. F. Kennedy. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cureFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.972687
5
Qian Jin, Min Cheng, Xia Xia, Yuqing Han, Jing Zhang, Pengbo Cao, Gangqiao Zhou. Down‐regulation of MYH10 driven by chromosome 17p13.1 deletion promotes hepatocellular carcinoma metastasis through activation of the EGFR pathwayJournal of Cellular and Molecular Medicine 2021; 25(24): 11142 doi: 10.1111/jcmm.17036
6
Nourhan Badwei. Hepatocellular Carcinoma Gene Expression: The New Era, Where It goes?iLIVER 2023; 2(1): 36 doi: 10.1016/j.iliver.2022.12.001
7
Yang Gu, Zhibin Yi, Ziheng Zhou, Jianyi Wang, Shan Li, Pingping Zhu, Nian Liu, Yuwei Xu, Lei He, Yanying Wang, Zusen Fan. SNORD88B-mediated WRN nucleolar trafficking drives self-renewal in liver cancer initiating cells and hepatocarcinogenesisNature Communications 2024; 15(1) doi: 10.1038/s41467-024-50987-6
8
Ming-Chin Yu, Chao-Wei Lee, Chia-Hung Lin, Chun-Hsing Wu, Yun-Shien Lee, Chia-Lung Tsai, Chi-Neu Tsai. Differential hypermethylation of the VTRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: Tumor marker prognostic studyInternational Journal of Surgery 2020; 79: 282 doi: 10.1016/j.ijsu.2020.05.016
9
Nia Adeniji, Renumathy Dhanasekaran. Genomic Landscape of HCCCurrent Hepatology Reports 2020; 19(4): 448 doi: 10.1007/s11901-020-00553-7
10
Hai Zhang, Shu Chen, Sanrong Xu, Xiangcheng Li, Stefania Pizzimenti. COTE1 Facilitates Intrahepatic Cholangiocarcinoma Progression via Beclin1‐Dependent Autophagy InhibitionBioMed Research International 2023; 2023(1) doi: 10.1155/2023/5491682
11
De Hu, Hidetaka Yamada, Katsuhiro Yoshimura, Tsutomu Ohta, Kazuo Tsuchiya, Yusuke Inoue, Kazuhito Funai, Takafumi Suda, Yuji Iwashita, Takuya Watanabe, Hiroshi Ogawa, Nobuhito Kurono, Kazuya Shinmura, Haruhiko Sugimura. High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung CancerCurrent Oncology 2023; 30(11): 9484 doi: 10.3390/curroncol30110687
12
Chun-Wei Huang, Tsung-Han Wu, Heng-Yuan Hsu, Kuang-Tse Pan, Chao-Wei Lee, Sio-Wai Chong, Song-Fong Huang, Sey-En Lin, Ming-Chin Yu, Shen-Ming Chen. Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular CarcinomaJournal of Personalized Medicine 2022; 12(4): 518 doi: 10.3390/jpm12040518
13
Song-Fong Huang, Sio-Wai Chong, Chun-Wei Huang, Heng-Yuan Hsu, Kuang-Tse Pan, Chien-Fu Hung, Tsung-Han Wu, Chao-Wei Lee, Chia-Hsun Hsieh, Ching-Ting Wang, Pei-Mei Chai, Ming-Chin Yu. Differential Response to Sorafenib Administration for Advanced Hepatocellular CarcinomaBiomedicines 2022; 10(9): 2277 doi: 10.3390/biomedicines10092277
14
Jiacheng Zhang, Keshuai Dong, Xin Zhang, Chunlei Li, Jia Yu, Weixing Wang. Characteristics of lactate metabolism phenotype in hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47065-0
15
Heng-Yuan Hsu, Jui-Hsiang Tang, Song-Fong Huang, Chun-Wei Huang, Sey-En Lin, Shu-Wei Huang, Chao-Wei Lee, Tsung-Han Wu, Ming-Chin Yu. Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular CarcinomaBiomedicines 2024; 12(3): 655 doi: 10.3390/biomedicines12030655
16
Ming-Chin Yu, Tsung-Han Wu, Chao-Wei Lee, Yun-Shien Lee, Jang-Hau Lian, Chia-Lung Tsai, Sen-Yung Hsieh, Chi-Neu Tsai. Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinomaBiomedical Journal 2021; 44(6): S73 doi: 10.1016/j.bj.2020.07.001